发明名称 Variant, recombinant beta-glucocerebrosidase proteins with increased stability and increased retained catalytic activity
摘要 Described herein are variant, recombinant β-glucocerebrosidase proteins characterized as having increased stability relative to recombinant wild-type β-glucocerebrosidase. Also provided herein are variant, recombinant β-glucocerebrosidase proteins characterized as retaining more catalytic activity relative to recombinant wild-type β-glucocerebrosidase. Further described herein are variant, recombinant β-glucocerebrosidase proteins that can have amino acid variations at one or more of the following positions: 316, 317, 321 and 145. Methods of making the variant, recombinant β-glucocerebrosidase proteins are also described as well as methods of treating patients having lysosomal storage diseases.
申请公布号 US9566316(B2) 申请公布日期 2017.02.14
申请号 US201614987204 申请日期 2016.01.04
申请人 AMICUS THERAPEUTICS, INC. 发明人 Do Hung V.
分类号 C07K1/00;C12N9/24;A61K38/00;A61K38/47;A61K31/445 主分类号 C07K1/00
代理机构 Servilla Whitney LLC 代理人 Servilla Whitney LLC
主权项 1. A composition comprising: a variant, recombinant human β-glucocerebrosidase protein, wherein the protein has at least one substitution relative to SEQ ID NO: 1, and wherein the substitution is selected from the group consisting of F316A relative to SEQ ID NO: 21,L317F relative to SEQ ID NO: 21,K321V relative to SEQ ID NO: 21,K321A relative to SEQ ID NO: 21,H145L relative to SEQ ID NO: 17,H145F relative to SEQ ID NO: 17,and combinations thereof; and isofagomine.
地址 Cranbury NJ US